Risperidone Kit
NDC 0480-1554
Product Information
Risperidone is a ANDA-approved product labeled by Teva Pharmaceuticals, Inc.. Risperidone is used to treat certain mental/mood disorders (such as schizophrenia, bipolar disorder, irritability associated with autistic disorder). It is supplied as a kit. This product entry covers the primary NDC 0480-1554 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 0480-1554?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- RISPERIDONE (UNII: L6UH7ZF8HC)
- RISPERIDONE (UNII: L6UH7ZF8HC) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- POLY(DL-LACTIC-CO-GLYCOLIC ACID), (75:25; 9500 MW) (UNII: SJN700Q87A)
- ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)
- SODIUM PHOSPHATE, DIBASIC, DIHYDRATE (UNII: 94255I6E2T)
- POLYSORBATE 20 (UNII: 7T1F30V5YH)
- CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM (UNII: K679OBS311)
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 402010 - risperiDONE 25 MG Extended Release Injection
- RxCUI: 402010 - risperidone 25 MG Injection
- RxCUI: 402011 - risperiDONE 37.5 MG Extended Release Injection
- RxCUI: 402011 - risperidone 37.5 MG Injection
- RxCUI: 402012 - risperiDONE 50 MG Extended Release Injection
* Please review the full disclaimer at the bottom of this page.